Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07635108
What this trial is testing

MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)

Who this might be right for
Prostate CancerOligo-metastatic Prostate CarcinomaOligometastatic Cancer+1 more
Odense University Hospital 48
Not applicableStudy completedNCT02232685
What this trial is testing

Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer

Who this might be right for
Prostate Cancer
Odense University Hospital 143
Testing effectiveness (Phase 2)Study completedNCT00055471
What this trial is testing

A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmsMetastases, Neoplasm
AstraZeneca 22
Testing effectiveness (Phase 2)Ended earlyNCT00585416
What this trial is testing

Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 23
Testing effectiveness (Phase 2)Study completedNCT02445976
What this trial is testing

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Who this might be right for
Prostate Cancer
Innocrin Pharmaceutical 197
Not applicableUnknownNCT02963155
What this trial is testing

Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration

Who this might be right for
Metastatic Prostate Cancer
Institut Paoli-Calmettes 30
Not applicableAvailableNCT05650476
What this trial is testing

Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pfizer
Testing effectiveness (Phase 2)Temporarily pausedNCT04071236
What this trial is testing

Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+1 more
National Cancer Institute (NCI) 90
Not applicableUnknownNCT05539300
What this trial is testing

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - Enzalutamide

Who this might be right for
Prostate Cancer
UMC Utrecht 150
Early research (Phase 1)Looking for participantsNCT06666270
What this trial is testing

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid CancerMetastatic Solid TumorOvarian Cancer+4 more
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04302454
What this trial is testing

Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy

Who this might be right for
Prostate Cancer
University Medical Center Groningen 280
Testing effectiveness (Phase 2)Study completedNCT06319469
What this trial is testing

The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention

Who this might be right for
Prostatic Hyperplasia
Beni-Suef University 140
Not applicableStudy completedNCT00909142
What this trial is testing

Bonefos and the Consumption of Analgesics

Who this might be right for
Bone Neoplasms
Bayer 149
Testing effectiveness (Phase 2)Study completedNCT01409200
What this trial is testing

Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis

Who this might be right for
Metastatic Malignant Neoplasm in Lymph NodeProstate Ductal AdenocarcinomaStage III Prostate Adenocarcinoma AJCC v7+1 more
M.D. Anderson Cancer Center 73
Testing effectiveness (Phase 2)Looking for participantsNCT06863272
What this trial is testing

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Who this might be right for
Castration-Resistant Prostatic CancerMetastasis
Merck Sharp & Dohme LLC 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT03317392
What this trial is testing

Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)Study completedNCT00271687
What this trial is testing

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisPalliative Care
AHS Cancer Control Alberta 30
Not applicableUnknownNCT04628806
What this trial is testing

Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells

Who this might be right for
Melanoma Stage IVSarcomaSquamous Cell Carcinoma+3 more
Charite University, Berlin, Germany 120
Very early researchActive Not RecruitingNCT06866548
What this trial is testing

Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
mCRPC
Shanghai Changzheng Hospital 7
Testing effectiveness (Phase 2)Study completedNCT01751438
What this trial is testing

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 180
Next Page